Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

P A van Zwieten

Showing results (1-10 of 579) with videos related to

Pageof 58
Sort By:
Advances in Experimental Medicine and Biology|January 1, 1997
Endothelial dysfunction in hypertensives. An uncertain associationP A van Zwieten
Blood Pressure. Supplement|January 1, 1997
Endothelial dysfunction in hypertension. A critical evaluationP A Van Zwieten
Blood Pressure. Supplement|July 11, 1998
Pharmacological profile of barnidipine: a single optical isomer dihydropyridine calcium antagonistP A van Zwieten
Pharmakopsychiatrie, Neuro-Psychopharmakologie|July 1, 1977
[Interaction between antihypertensive agents and psychotropic drugs (author's transl)]P A van Zwieten
Arzneimittel-Forschung|January 1, 1985
Receptors involved in the regulation of vascular toneP A van Zwieten
Therapie|July 1, 1972
[Role of alpha-sympathomimetic agents in the central nervous system. Study of the central effects of adrenergic drugs by injection into the vertebral artery]P A Van Zwieten
Clinical and Experimental Hypertension (New York, N.Y. : 1993)|July 28, 1999
Centrally acting antihypertensive drugs. Present and futureP A van Zwieten
American Heart Journal|February 1, 1993
Protective effects of calcium antagonists in different organs and tissuesP A van Zwieten
Journal of Hypertension. Supplement : Official Journal of the International Society of Hypertension|September 1, 1996
The role of public health authorities, scientific societies and the pharmaceutical industry in planning and conducting intervention trialsP A van Zwieten
Cardiologia (Rome, Italy)|May 1, 1996
[The clinical pharmacology of calcium antagonists: new aspects and insights]P A van Zwieten
Pageof 58

Showing results (1-10 of 579) with videos related to

Sort By:
Pageof 58
Advances in Experimental Medicine and Biology|January 1, 1997
Endothelial dysfunction in hypertensives. An uncertain associationP A van Zwieten
Blood Pressure. Supplement|January 1, 1997
Endothelial dysfunction in hypertension. A critical evaluationP A Van Zwieten
Blood Pressure. Supplement|July 11, 1998
Pharmacological profile of barnidipine: a single optical isomer dihydropyridine calcium antagonistP A van Zwieten
Pharmakopsychiatrie, Neuro-Psychopharmakologie|July 1, 1977
[Interaction between antihypertensive agents and psychotropic drugs (author's transl)]P A van Zwieten
Arzneimittel-Forschung|January 1, 1985
Receptors involved in the regulation of vascular toneP A van Zwieten
Therapie|July 1, 1972
[Role of alpha-sympathomimetic agents in the central nervous system. Study of the central effects of adrenergic drugs by injection into the vertebral artery]P A Van Zwieten
Clinical and Experimental Hypertension (New York, N.Y. : 1993)|July 28, 1999
Centrally acting antihypertensive drugs. Present and futureP A van Zwieten
American Heart Journal|February 1, 1993
Protective effects of calcium antagonists in different organs and tissuesP A van Zwieten
Journal of Hypertension. Supplement : Official Journal of the International Society of Hypertension|September 1, 1996
The role of public health authorities, scientific societies and the pharmaceutical industry in planning and conducting intervention trialsP A van Zwieten
Cardiologia (Rome, Italy)|May 1, 1996
[The clinical pharmacology of calcium antagonists: new aspects and insights]P A van Zwieten
Pageof 58